MICA and neoplasm: developed a novel tumor vaccine targeting MICA and MICB stress proteins expressed due to DNA damage, which effectively enhanced the immune system’s ability to recognize and kill cancer cells by enhancing the density of MICA/B proteins on the surface of cancer cells (7).